-
Exploring the Future of Oncolytic Immunotherapy
Replimune is pioneering a novel class of cancer treatments based on oncolytic immunotherapies—herpes simplex viruses engineered to replicate within tumors, kill cancer cells directly, and spark systemic anti-tumor immunity ([Replimune][1]). The RPx Platform Replimune’s RPx platform uses modified HSV-1 backbones enhanced with immune‑stimulating transgenes: RP3: Adds co‑stimulatory ligands (CD40L and 4‑1BBL) to further stimulate immune…
-
From Wearables to Blockchain: How Emerging Tech is Reinventing Healthcare
Imagine a world where your smartwatch doesn’t just count your steps—it detects irregular heartbeats, flags potential symptoms before you notice them, and instantly alerts your doctor. Meanwhile, AI analyzes that data in real time, predicts complications before they happen, and securely stores everything on a tamper-proof digital ledger. This isn’t sci-fi. It’s the future of…
-
Physicians Leading the Health Tech Revolution
In today’s rapidly evolving medical landscape, technology is transforming patient care at breakneck speed. From telemedicine and wearable devices to AI-driven diagnostics, these innovations are not just changing tools—they’re reshaping the delivery of care entirely. But the key to meaningful progress lies in the people using these tools: physicians. Harvard Medical School argues that doctors…
zuwire
Wiring the Future of Health and Technology
